Clinical trial
Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II
NCT00186043 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186043 |
|---|---|
| Title | Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II |
| Official title | A Double-Blind, Placebo-Controlled Trial of Seroquel for the Treatment of Dysphoric Hypomania in Bipolar II Patients |
| Lead sponsor | Stanford University, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar II Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine/Seroquel, Placebo |
| Enrollment | 55 |
| Start date | Aug 1, 2008 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: